<DOC>
	<DOC>NCT02084485</DOC>
	<brief_summary>The study was performed to assess the effect of PH-797804 on neutrophils (white cells) in the sputum after a challenge with an endotoxin (inhaled LPS). Neutrophils are a sign of inflammation and PH-797804 is being developed as a potential anti-inflammatory treatment for patients with Chronic Obstructive Pulmonary Disease (COPD).</brief_summary>
	<brief_title>PH-797804 LPS Study in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male or female (WONCBP), non atopic volunteers aged 1850 years Able to produce sputum Current Smokers Abnormal liver function test Respiratory Tract Infection within 4 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>LPS</keyword>
</DOC>